Market overview:
Bacillus Coagulans are friendly bacteria that help maintain a balanced microbiome in the digestive system when consumed as probiotic supplements or food and beverage products. Bacillus Coagulans probiotics are helpful in maintaining and improving gut health, immunity, and digestion.
The global Bacillus Coagulans Market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increased focus on gut health and preventive healthcare is a key trend contributing to the growth of the Bacillus Coagulans Market. Consumers are increasingly becoming aware of the importance of gut health and its role in overall well-being. Regular consumption of probiotic supplements containing Bacillus Coagulans is considered beneficial in supporting digestive health, immunity, and reducing complications like irritable bowel syndrome. This growing consumer focus on preventive healthcare through nutrition is driving the demand for probiotic supplements, food, and beverages with Bacillus Coagulans. Manufacturers are also launching new product varieties targeting this demand.
SWOT Analysis
Strength: Bacillus coagulans is safe, natural and non-pathogenic which makes it suitable for various health supplement applications. It can survive stomach acids and colonize in gastrointestinal tract.
Weakness: High production costs and stability issues during processing and shelf life of products.
Opportunity: Rising demand for probiotic supplements globally. Growing health and wellness trends driving demand for digestive health products.
Threats: Stiff competition from other probiotic strains such as Bifidobacterium and Lactobacillus. Stringent regulations for new probiotic strains approval.
Key Takeaways
The Global Bacillus Coagulans Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The global Bacillus Coagulans Market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030.
Regional analysis Asia Pacific region holds highest share currently owing to increasing spending on probiotic dietary supplements. China is fastest growing market in the region.
Key players operating in the Bacillus Coagulans are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech. Key players operating in the Bacillus Coagulans market are focusing on expanding their production facilities and product portfolio to cater to the rising demand. Ganeden is a leading player with wide range of Bacillus Coagulans based probiotic products. Sabinsa Corporation is another major player headquartered in USA, focusing on research and clinical studies backing health benefits of Bacillus Coagulans.
